Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythromycin A 11,12-methylene acetal.

E Hunt1, D J Knowles, C Shillingford

  • 1Beecham Pharmaceuticals, Chemotherapeutic Research Centre, Betchworth, Surrey, UK.

The Journal of Antibiotics
|November 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Racial and Ethnic Representation in Nephrolithiasis Guidelines: Are They Generalizable?

Urology·2024
Same author

Examining Motivation of First-Year Undergraduate Anatomy Students Through the Lens of Universal Design for Learning (UDL): A Single Institution Study.

Medical science educator·2023
Same author

A feasibility study on a novel well-being intervention for university students.

Irish journal of psychological medicine·2021
Same author

Genetic and environmental overlap between borderline personality disorder traits and psychopathy: evidence for promotive effects of factor 2 and protective effects of factor 1.

Psychological medicine·2014
Same author

SOAR as a world view, not a theory.

The Behavioral and brain sciences·2014
Same author

TRiM: an organizational response to traumatic events in Cumbria Constabulary.

Occupational medicine (Oxford, England)·2013

Erythromycin A derivatives were synthesized and tested for antibacterial effects. The methylene acetal derivative demonstrated potent activity against Gram-positive bacteria in laboratory settings.

Area of Science:

  • Medicinal Chemistry
  • Microbiology

Background:

  • Erythromycin A is a crucial macrolide antibiotic.
  • Modifications of Erythromycin A are explored to enhance antibacterial properties.

Purpose of the Study:

  • To synthesize novel Erythromycin A derivatives, specifically the 11,12-methylene acetal.
  • To evaluate and compare the in vitro antibacterial activity of these derivatives against Erythromycin A and its cyclic carbonate.

Main Methods:

  • Synthesis of Erythromycin A 11,12-methylene acetal (5).
  • Preparation of related derivatives: 9-methoxime, 9-dihydro, and 8-hydroxy.
  • Comparative in vitro antibacterial assays against Gram-positive and potentially Gram-negative organisms.

Main Results:

Related Experiment Videos

  • The synthesized Erythromycin A 11,12-methylene acetal (5) exhibited significant antibacterial activity.
  • Activity was notably effective against Gram-positive microorganisms in in vitro tests.

    • Conclusions:

    • Erythromycin A 11,12-methylene acetal is a promising compound for targeting Gram-positive bacterial infections.
    • Further investigation into its mechanism and spectrum of activity is warranted.